Riskpilot← Back to searchSign inGet full accessMISSIONPHARMA GROUP ApS
APSDissolvedCVR 29782792Vassingerødvej 9Ikke-finansielle holdingselskaber · NACE 642020Est. 2006— employees
Revenue 2023
DKK 0
EBITDA margin
—
-116% vs 2022
Equity ratio
97.8%
Financial strength
Net profit 2023
DKK 118,1M
+126% vs 2022
| Revenue | DKK 0 | — |
| EBITDA | DKK -110K | -116% |
| Net profit | DKK 118,1M | +126% |
| Total assets | DKK 357,5M | +9% |
| Equity | DKK 349,7M | +8% |
| Employees | — | — |
Legal name
MISSIONPHARMA GROUP ApS
CVR number
29782792
Legal form
Anpartsselskab
NACE code
642020 · Ikke-finansielle holdingselskaber
Founded
4. oktober 2006
Share capital
DKK 125.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2023-03-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer i forening, eller af to direktører i forening, eller af den samlede bestyrelse
Address
Vassingerødvej 9
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | — | — | — | — | — | — | — | -122 | -57 | -99 | -51 | -2 | -1 | -60 | -51 | -66 | -51 | -110 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | — | — | — | — | — | — | — | -122 | -57 | -99 | -51 | -2 | -1 | -60 | -51 | -66 | -51 | -110 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39.443 | 63.434 | 68.516 | 73.208 | 70.053 | 1.960 | 32.946 | 16.917 | 78.136 | 52.476 | 118.212 |
| Profit before tax | — | — | — | — | — | — | — | 39.321 | 63.377 | 68.417 | 73.157 | 70.051 | 1.959 | 32.886 | 16.866 | 78.070 | 52.425 | 118.102 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -104 | 46 | -25 | -18 | -3 | -1 | -20 | -1 | 29 | 113 | -37 |
| Net profit | — | — | — | — | — | — | — | 39.425 | 63.331 | 68.442 | 73.175 | 70.054 | 1.960 | 32.906 | 16.867 | 78.041 | 52.312 | 118.139 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 242.283 | 275.319 | 292.634 | 311.922 | 320.598 | 329.568 | 306.964 | 289.394 | 348.938 | 329.049 | 357.482 |
| Equity | — | — | — | — | — | — | — | 239.453 | 272.006 | 289.837 | 308.649 | 318.480 | 319.264 | 296.857 | 284.762 | 348.180 | 322.934 | 349.722 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.667 | 3.313 | 2.797 | 3.273 | 2.118 | 10.304 | 10.107 | 4.632 | 758 | 6.115 | 7.760 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.667 | 3.313 | 2.797 | 3.273 | 2.118 | 10.304 | 10.107 | 4.632 | 758 | 6.115 | 7.760 |
EBITDA margin
-11000000.0%
This company
15.8%
Market median
-69620353% vs market
20072023
Equity ratio
97.8%
This company
38.2%
Market median
+156% vs market
20072023
Return on equity
33.8%
This company
18.4%
Market median
+84% vs market
20072023
Net profit margin
11813900000.0%
This company
8.1%
Market median
+145850617184% vs market
20072023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20072023
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20072023
- Annual report 2023Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via CVR / Virk · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via CVR / Virk · Period 2020-04-01 – 2021-03-31
- Annual report 2020Filed via CVR / Virk · Period 2019-04-01 – 2020-03-31
- Annual report 2019Filed via CVR / Virk · Period 2018-04-01 – 2019-03-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-03-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-05-01 – 2012-12-31
- Annual report 2012Filed via CVR / Virk · Period 2011-05-01 – 2012-04-30
- Annual report 2011Filed via CVR / Virk · Period 2010-05-01 – 2011-04-30
- Annual report 2010Filed via CVR / Virk · Period 2009-05-01 – 2010-04-30
- Annual report 2009Filed via CVR / Virk · Period 2008-05-01 – 2009-04-30
- Annual report 2008Filed via CVR / Virk · Period 2007-05-01 – 2008-04-30
- Annual report 2007Filed via CVR / Virk · Period 2006-10-04 – 2007-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CM Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
PL Management | Management | 2012 | — | — |
AP Management | Management | 2021 | — | — |
PG Management | Management | 2006 | — | — |
MM Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Deputy Chairman | 2012 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2012 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2012 | — | — | |
| Deputy Chairman | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2017 | |
Ginnerup Capital ApS | Company | 20.0% | 20.0% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MISSIONPHARMA GROUP ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christian Monrad Overgaard | Chief Executive Officer | 0 companies |
| Poul Lindof | Management | 0 companies |
| Alexandre Pierre Jean Vialatte | Management | 0 companies |
| Paule Georgette Ginnerup | Management | 0 companies |
| Mikkel Mørkedal Wakefield | Chief Executive Officer | 0 companies |
| Annie Renée Simonne Dateu | Board of Directors | 0 companies |
| Denis Georges Fernand Maurice | Deputy Chairman | 0 companies |
| Patricia Hec | Board of Directors | 0 companies |
| Jean-Marc Pierre Rene Leccia | Chairman | 0 companies |
| Ilona Maureen Fischer | Board of Directors | 0 companies |
| Aymeric Erouart | Board of Directors | 0 companies |
| Eric Pierre Jean Muris | Board of Directors | 0 companies |
| Jean-Marc Pierre René Leccia | Board of Directors | 0 companies |
| Kim Erik Ginnerup | Deputy Chairman | 0 companies |